Job title: Executive Vice President & CSO
Dhaval Patel leads UCB’s research organization with the main goal of bringing scientific innovation to patients and helping them live the life they choose. Dhaval Patel is a medical doctor and holds a PhD in Microbiology and Immunology. He comes to UCB from Novartis, based in their headquarters in Basel, Switzerland, where for 11 years he led various biomedical research teams in areas of neurology, autoimmunity, transplantation
and inflammation. In 2010, he became the Head of Research for the Novartis Institutes for BioMedical Research (NIBR) Europe. For 12 years prior to crossing into industry, Dhaval made a strong mark in the halls of academia
and research, specifically at Duke University Medical Center and the University of North Carolina (UNC) at Chapel Hill in North Carolina in the US. He authored and co-authored over 100 thought-leading publications and presentations. He is a member of UCB’s Executive Committee.
Opening Keynote Panel Discussion: What’s Next in Dermatology Drug Development? 9:00 am
• Establishing the current landscape and state-of-the art in dermatology drug development – latest advances and challenges • Lessons learned for rational and effective drug development in dermatology – discussing a ‘blueprint’ of what success looks like in dermatology drug development • Analysing the end-to-end pain points that accompany dermatology programs – from improving preclinical…Read more
day: Day One